2009 Pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11626-11637

  Ma, Wenjun ^a   Belisle, Sarah E ^b   Mosier, Derek ^a   Li, Xi ^a   Stigger Rosser, Evelyn ^c   Liu, Qinfang ^a   Qiao, Chuanling ^a,d   Elder, Jake ^a   Webby, Richard ^c   Katze, Michael G ^b   Richt, Juergen A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Harbin Veterinary Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING DISORDER; CELL DEATH; CONTROLLED STUDY; COUGHING; FEVER; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HA GENE; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA VIRUS A H1N1; LIPID METABOLISM; LUNG LESION; NONHUMAN; NOSE CAVITY; NP GENE; NUCLEOTIDE SEQUENCE; PA GENE; PATHOGENESIS; PB1 GENE; PB2 GENE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SNEEZING; STRAIN DIFFERENCE; SWINE; SWINE INFLUENZA VIRUS; SYMPTOM; UPREGULATION; VIRUS GENE; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; LIPID METABOLISM; LUNG; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE DATA; NASAL MUCOSA; ORTHOMYXOVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; SWINE; SWINE DISEASES; VIRUS SHEDDING;

ORTHOMYXOVIRIDAE; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 80655143492     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05705-11     Document Type: Article

References (60)

1. Baskin, C. R., et al. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455-3460.
2. Belser, J. A., et al. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol. 84:4194-4203.
3. Billharz, R., et al. 2009. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 83: 10557-10570.
4. Brazma, A., et al. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29:365-371.
5. Brookes, S. M., et al. 2010. Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One 5:e9068.
6. Bruant, G., et al. 2009. Two distinct groups of porcine enteropathogenic Escherichia coli strains of serogroup O45 are revealed by comparative genomic hybridization and virulence gene microarray. BMC Genomics 10: 402.
7. Chan, R. B., L. Tanner, and M. R. Wenk. 2010. Implications for lipids during replication of enveloped viruses. Chem. Phys. Lipids. 163:449-459.
8. Chen, W., et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312.
9. Cilloniz, C., et al. 2010. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J. Virol. 84:7613-7624.
10. Das, K., et al. 2008. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 105:13093-13098.
11. Garten, R. J., et al. 2009. Antigenic and genetic characteristics of swineorigin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
12. Gladue, D. P., et al. 2010. Patterns of gene expression in swine macrophages infected with classical swine fever virus detected by microarray. Virus Res. 151:10-18.
13. Goure, J., et al. 2009. Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae. BMC Genomics 10:88.
14. Hai, R., et al. 2010. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 84:4442-4450.
15. Hale, B. G., R. E. Randall, J. Ortin, and D. Jackson. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376.
16. Hale, B. G., et al. 2010. Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J. Gen. Virol. 91:1737-1742.
17. Hale, B. G., et al. 2010. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J. Virol. 84:6909-6922.
18. Heaton, N. S., and G. Randall. 2011. Multifaceted roles for lipids in viral infection. Trends Microbiol. 19:368-375.
19. Itoh, Y., et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025.
20. Jackson, D., M. J. Hossain, D. Hickman, D. R. Perez, and R. A. Lamb. 2008. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 105: 4381-4386.
21. Kash, J. C., et al. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-581.
22. Kitikoon, P., et al. 2011. Brief report: molecular characterization of a novel reassorted pandemic H1N1 2009 in Thai pigs. Virus Genes 43:1-5.
23. Kobasa, D., et al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323.
24. Krumbholz, A., et al. 2011. Current knowledge on PB1-F2 of influenza A viruses. Med. Microbiol. Immunol. 200:69-75.
25. Lange, E., et al. 2009. Pathogenesis and transmission of the novel swineorigin influenza virus A/H1N1 after experimental infection of pigs. J. Gen. Virol. 90:2119-2123.
26. Lemaitre, M., and F. Carrat. 2010. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect. Dis. 10:162.
27. Lin, C. M., et al. 2011. Immunopathological characterization of porcine circovirus type 2 infection-associated follicular changes in inguinal lymph nodes using high-throughput tissue microarray. Vet. Microbiol. 149:72-84.
28. Liu, Y., et al. 2008. Increased expression of the peroxisome proliferatoractivated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection. Vet. Immunol. Immunopathol. 124: 82-92.
29. Liu, Y., et al. 2009. Activation of peroxisome proliferator-activated receptorgamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate Immun. 15:169-178.
30. Ma, W., et al. 2011. Pathogenicity of swine influenza viruses possessing an avian or swine-origin PB2 polymerase gene evaluated in mouse and pig models. Virology 410:1-6.
31. Ma, W., et al. 2007. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. U. S. A. 104:20949-20954.
32. Maines, T. R., et al. 2009. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487.
33. Manicassamy, B., et al. 2010. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6:e1000745.
34. McAuley, J. L., et al. 2007. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240-249.
35. Medina, R. A., et al. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat. Commun. 1:28.
36. Moser, R. J., A. Reverter, C. A. Kerr, K. J. Beh, and S. A. Lehnert. 2004. A mixed-model approach for the analysis of cDNA microarray gene expression data from extreme-performing pigs after infection with Actinobacillus pleuropneumoniae. J. Anim. Sci. 82:1261-1271.
37. Munster, V. J., et al. 2009. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325:481-483.
38. Obenauer, J. C., et al. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311:1576-1580.
39. Ozawa, M., et al. 2011. Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J. Virol. 85:4596-4601.
40. Palmer, D. F., M. T. Coleman, W. D. Dowdle, and G. O. Schild. 1975. Advanced laboratory techniques for influenza diagnosis. U.S. Department of Health, Education, and Welfare, Washington, DC.
41. Pasma, T., and T. Joseph. 2010. Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg. Infect. Dis. 16:706-708.
42. Peiris, J. S., et al. 2001. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J. Virol. 75:9679-9686.
43. Pereda, A., et al. 2010. Pandemic (H1N1) 2009 outbreak on pig farm, Argentina. Emerg. Infect. Dis. 16:304-307.
44. Pig Disease Information Centre. 2011. Pig herd outbreaks of pandemic influenza H1N1. Pig Disease Information Centre, Cambridge, United Kingdom. http://www.pighealth.com/influenza.htm.
45. Richt, J. A., et al. 2003. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J. Clin. Microbiol. 41:3198-3205.
46. Safronetz, D., et al. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85:1214-1223.
47. Seo, S. H., E. Hoffmann, and R. G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8:950-954.
48. Skovgaard, K., S. Mortensen, M. Boye, J. Hedegaard, and P. M. Heegaard. 2010. Hepatic gene expression changes in pigs experimentally infected with the lung pathogen Actinobacillus pleuropneumoniae as analysed with an innate immunity focused microarray. Innate Immun. 16:343-353.
49. Smith, G. J., et al. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
50. Sreta, D., et al. 2010. Pandemic (H1N1) 2009 virus on commercial swine farm, Thailand. Emerg. Infect. Dis. 16:1587-1590.
51. Steel, J., et al. 2010. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J. Virol. 84:21-26.
52. Sun, Y., et al. 2011. High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 108:4164-4169.
53. USDA National Veterinary Services Laboratories. 2010. 2009 Pandemic H1N1 influenza presumptive and confirmed results, January 19, 2010. USDA National Veterinary Services Laboratories, Ames, IA. http://www.usda.gov/documents/CHART-SAMPLES_FOR_CY2009_011910.pdf.
54. Vijaykrishna, D., et al. 2010. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 328:1529.
55. Vincent, A. L., et al. 2010. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respi. Viruses 4:53-60.
56. Vincent, A. L., et al. 2006. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet. Microbiol. 118:212-222.
57. Vincent, A. L., W. Ma, K. M. Lager, B. H. Janke, and J. A. Richt. 2008. Swine influenza viruses a North American perspective. Adv. Virus Res. 72:127-154.
58. Weingartl, H. M., et al. 2009. Experimental infection of pigs with the human 1918 pandemic influenza virus. J. Virol. 83:4287-4296.
59. Weingartl, H. M., et al. 2010. Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd. J. Virol. 84:2245-2256.
60. World Health Organization. 6 August 2010, posting date. Pandemic (H1N1) 2009-update 112. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/don/2010_08_06/en/index.html.